NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said first-quarter revenues increased nearly 240 percent as R&D spending rose 55 percent and profit jumped 200 on combined sales and spending stemming from the merger of Thermo Electron and Fisher Scientific.
 
Total receipts for the three months ended March 31 increased to $2.3 billion from $684.3 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.